Aromatase resistance mechanisms in model systems in vivo

Journal of Steroid Biochemistry and Molecular Biology

Volumn 118, Issue 4-5, 2010, Pages 283-287

  Brodie, Angela ^a   MacEdo, Luciana ^a   Sabnis, Gauri ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Aromatase inhibitors; Breast cancer; Estrogen; Resistance

Indexed keywords

ANASTROZOLE; AROMATASE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LETROZOLE; TAMOXIFEN; TRASTUZUMAB; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CANCER; CANCER CELL; CANCER HORMONE THERAPY; CELL ISOLATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BREAST TUMOR; DRUG RESISTANCE; METABOLISM; NUDE MOUSE; TUMOR CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; RECEPTORS, ESTROGEN;

EID: 77950362569     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.09.004     Document Type: Conference Paper

References (14)

1. A.M. Brodie, D. Jelovac, L. Macedo, G. Sabnis, S. Tilghman, O.G. Goloubeva, Therapeutic observations in MCF-7 aromatase xenografts, Clin. Cancer Res. 11 (2005) 884s-888s.
2. B.J. Long, D. Jelovac, V. Handratta, A. Thiantanawat, N. MacPherson, J. Ragaz, O.G. Goloubeva, A.M. Brodie, Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model, J. Natl. Cancer Inst. 96 (6) (2004) 456-465.
3. B.J. Long, D. Jelovac, A. Thiantanawat, A.M. Brodie, The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model, Clin. Cancer Res. 8 (7) (2002) 2378-2388.
4. D. Jelovac, G. Sabnis, B.J. Long, L. Macedo, O.G. Goloubeva, A.M. Brodie, Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole, Cancer Res. 65 (12) (2005) 5380-5389.
5. D. Zhou, D. Pompon, S. Chen, Stbale expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening, Cancer Res. 50 (21) (1990) 6949-6954.
6. G. Sabnis, A. Schayowitz, O. Goloubeva, L. Macedo, A. Brodie, Trastuzumab reverses letrozole resistance and amplifies the sensitivity of breast cancer cells to estrogen, Cancer Res. 69 (4) (2009) 1416-1428.
7. W. Yue, J. Wang, A. Savinov, A. Brodie, Effect of aromatase inhibitors on the growth of mammary tumors in a nude mouse model, Cancer Res. 55 (14) (1995) 3073-3077.
8. B.J. Long, S.L. Tilghman, W. Yue, A. Thiantanawat, D.N. Grigoryev, A.M. Brodie, The steroidal antiestrogen ICI, 182, 780 is an inhibitor of cellular aromatase activity, J. Steroid Biochem. Mol. Biol. 67 (4) (1998) 293-304.
9. A.A. Kazi, J.M. Jones, R.D. Koos, Chromatin immunoprecipitaiton analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter, Mol. Endocrinol. 19 (8) (2005) 2006-2019.
10. C. Zhou, D. Zhou, J. Esteban, J. Murai, P.K. Siiteri, S. Wilczynski, S. Chen, Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction, J. Steroid Biochem. Mol. Biol. 59 (2) (1996) 163-171.
11. G.J. Sabnis, L.F. Macedo, O. Goloubeva, A. Schayowitz, A.M. Brodie, Stopping treatment can reverse acquired resistance to letrozole, Cancer Res. 68 (12) (2008) 4518-4524.
12. X. Yang, D.L. Phillips, A.T. Ferguson, W.G. Nelson, J.G. Herman, N.E. Davidson, Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alphanegative breast cancer cells, Cancer Res. 61 (19) (2001) 7025-7029.
13. G. Sabnis, O. Goloubeva, L. Macedo, R. Gilani, L. Gediya, V. Njar, A. Brodie, Comibination ofHDACinhibitor entinostat (SNDX-275) with letrozole provides control over increased growth in MDA-MB-231 xenograft models, Cancer Res. 6128 (Suppl. 2) (2009) 398s.
14. L.F. Macedo, G.J. Sabnis, O.G. Goloubeva, A. Brodie, Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model, Cancer Res. 68 (9) (2008) 4518-4524.